Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04446676

Impact of the Type of Stabilization in the Two-stage Knee Reimplantation on Reinfection - Prospective, Randomized Study.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Prof A Gruca Teaching Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

Participants after first-stage of knee infection reimplantation will be assign to one of two groups: with stem vs. with sleeve. Investigators will check participants on clinical, laboratory and reinfection signs. The main hypothesis is that better mechanical stability of endoprosthesis with sleeves will support infection treatment.

Detailed description

All participants will be treated because of periprosthetic joint infection of the knee, after primary arthroplasty. All participants will be treated with two-stage protocol. In first stage debridement and spacer implantation will be performed. After 6-week antibiotics, when will be absent clinical or laboratory signs of reinfection, second stage will be performed. All participants upon fulfillment all inclusion and exclusion criteria will sign informed consent. With computer software patients will be randomized to one of two groups: with stem vs. with sleeve. After operation all patients will get target antibiotics for 3 weeks. Pre-operation and after on periodic controls will checked the Knee Society Score, The Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC), Visual Analogue Scale. After 2-year observation evaluation of reinfection rate will be performed in both groups.

Conditions

Interventions

TypeNameDescription
DEVICEstabilization with stemIn both groups revision endoprosthesis of knee will be implanted with stem or sleeve stabilization.
DEVICEstabilization with sleeveIn both groups revision endoprosthesis of knee will be implanted with stem or sleeve stabilization.

Timeline

Start date
2020-11-17
Primary completion
2026-07-01
Completion
2027-01-01
First posted
2020-06-25
Last updated
2022-03-15

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT04446676. Inclusion in this directory is not an endorsement.